Philippine Measles Epidemic Tops 14,000 Cases And Still Rising
(Bloomberg) -- The number of cases of measles in the Philippines has exceeded more than 14,000 and the count is still rising even as the government steps up its campaign against a vaccine scare that was triggered by deaths allegedly caused by Dengvaxia, a vaccine against dengue.
The government recorded 14,938 cases and 238 deaths from measles as of Feb. 28, Health Department Undersecretary Eric Domingo said in a mobile phone text message, adding that “the number of cases is still rising.”
“We are continuing with our intensive campaign to vaccinate the vulnerable unprotected children,” Domingo said.
The Philippines declared a measles outbreak in Manila early February as infections and fatalities from the highly contagious respiratory viral disease spiked.
Deaths due to measles escalated to 200 last year from about 50 in 2017 as the deaths allegedly caused by Dengvaxia, a vaccine against dengue that was given free by President Rodrigo Duterte's predecessor, sparked a scare and drove parents to shun the government's free immunization drive.
The Philippines banned Dengvaxia in February and government prosecutors on Friday said they found probable cause to indict executives of Dengue-manufacturer Sanofi and government health officials for at least 10 deaths allegedly linked to the vaccine.
To contact the reporter on this story: Ian Sayson in Manila at isayson@bloomberg.net
To contact the editors responsible for this story: Shamim Adam at sadam2@bloomberg.net, John McCluskey
©2019 Bloomberg L.P.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
